🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New publication by Munaza Riaz, PhD Steven Smith and Dr. Haesuk Park in Pharmacotherapy - Effectiveness of #Sacubitril/#Valsartan Versus Aldosterone Antagonists in #HeartFailure with reduced Ejection Fraction: A Retrospective Cohort Study accpjournals.onlinelibrary.wiley.com/doi/abs/10.100…

Doctor vs Patient: Who knows more?

📢Order your free COVID at-home tests now! special.usps.com/testkits "One order includes 4 individual rapid antigen COVID-19 tests. Orders will ship free starting in late January"

New publication by UF Center for Drug Evaluation and Safety trainee @PhuongTran26i in #ClinDrugInvestig - An Umbrella Review of the Cost Effectiveness of Human Papillomavirus Vaccines Munaza Riaz, PhD pubmed.ncbi.nlm.nih.gov/35488964/

Curious about which medications are used by patients with heart failure and preserved ejection fraction early after diagnosis? Check out our recent publication on utilization trends of these pharmacotherapies over a period of 13 years. Steven Smith doi.org/10.1016/j.ahjo…

New publication by UF Center for Drug Evaluation and Safety trainee Munaza Riaz, PhD in AHJPlus - Trends in pharmacotherapy utilization among patients with heart with preserved ejection fraction Steven Smith SerenaJGuo #Dr. Haesuk Park sciencedirect.com/science/articl…

Graduate student Munaza Riaz is one of 13 recipients of an ISPOR student travel grant to attend the society's meeting in Boston. #UFPharmacy pop.pharmacy.ufl.edu/2023/03/14/gra…

Excited to share that I’ll be presenting my research work on pharmacotherapies in HFpEF at #ISPORAnnual. Visit our posters on May 8 (CO47) and May 9 (CO141 & CO138) between 5:45 pm - 6:45 pm ET. See you at the conference. #RWE #HEOR

Compared with canagliflozin or dapagliflozin use, empagliflozin use was associated with decreased risk of HF-related and all-cause hospitalizations. buff.ly/3rsr55f Munaza Riaz, PhD @UFCODES ACCP Cardiology PRN

We're thrilled to share our latest publication. We did not find difference in hospitalizations between patients with HFpEF using ARBs or sacubitril valsartan. #HeartFailure #Research #Cardiology #RealWorldStudy academic.oup.com/ajhp/article-a…

New publication by UF Center for Drug Evaluation and Safety trainee Munaza Riaz, PhD in Sleep Research Society – 0870 Association Between Narcolepsy and Cardiovascular Outcomes: A Matched Cohort Study Adjusting for Medication Use academic.oup.com/sleep/article/…… Jenny Lo-Ciganic UF Pharmacy

I'm excited to announce the publication of our latest article titled "Comparative Genitourinary Safety of In-class Sodium-Glucose Cotransporter-2 Inhibitors among Patients with Heart Failure with Preserved Ejection Fraction: A Cohort Study.”doi.org/10.1007/s40256…

Narcolepsy is a risk factor for cardiovascular disease and adverse cardiac events sleepmeeting.org/narcolepsy-is-… UF Center for Drug Evaluation and Safety

Two new studies to be presented at the #SLEEP2024 annual meeting show that #narcolepsy is an independent risk factor for #cardiovascular disease and adverse #cardiac events. ow.ly/8wzC50S90Rr

New publication by UF Center for Drug Evaluation and Safety trainee Munaza Riaz, PhD in Amitabh Prakash – Comparative Genitourinary Safety of In-class Sodium-Glucose Cotransporter-2 Inhibitors among Patients with Heart Failure with Preserved Ejection Fraction link.springer.com/article/10.100…

Dr. Riaz’s heart failure study was recognized at the 2024 ISPOR Conference. Munaza Riaz, PhD, Ph.D., is a 2023 graduate of the University of Florida College of Pharmacy’s department of pharmaceutical outcomes and policy. UF Pharmacy

New article: Hydroxychloroquine use in patients with heart failure and #autoimmune disease is linked to a lower risk of heart failure-related and all-cause hospitalizations. 👉 May offer benefits beyond autoimmune disorders. doi.org/10.1111/joim.2… #Cardiology #HCQHeartHealth